Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 345 of 6351
-
New combo therapy aims to wipe out breast cancer before surgery
Disease control Not yet recruitingThe goal of this interventional study is to determine pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) and Efti treatment. This is a prospective single arm interventional trial in patients with early-stage HR+/HER2 -ve breast cancer (Stage I-III) who are …
Phase 2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New scan could spare throat cancer patients from unnecessary radiation side effects
Disease control Not yet recruitingOropharyngeal cancer (OPC) is the most common type of head and neck cancer. The current standard treatment for this cancer is radiotherapy (RT) of the tumour and lymph nodes of both sides of the neck, combined with concurrent chemotherapy for advanced stages. Even though a small …
Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Don't wash that baby! study tests if keeping vernix on prevents eczema
Prevention Not yet recruitingAtopic dermatitis (AD), also known as eczema, is a common chronic inflammatory skin disease that usually begins in infancy and causes significant itching, discomfort, and sleep disturbance. It affects up to one in five children worldwide and represents a growing public-health pro…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Simple supplement may slow vision loss in rare eye disease
Disease control Not yet recruitingThe goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional changes of the retina in people with MacTel type 2. The main questions it aims to answer are: * Does serine slow the progre…
Phase 3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Cannabis extract VER-01 put to the test for stubborn leg pain
Symptom relief Not yet recruitingThe aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pa…
Phase 3 • Sponsor: Vertanical GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New CPR technique could save more newborn lives
Disease control Not yet recruitingNewborn infants who require cardiopulmonary resuscitation at birth receive chest compression using a 3-Compression to 1-Ventilation (3:1 C:V) ratio. However, the optimal chest compression technique during cardiopulmonary resuscitation is uncertain and identified as a critical gap…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New rehab program aims to protect cancer Survivors' hearts
Disease control Not yet recruitingCancer therapy-related cardiac dysfunction (CTRCD) has become a major cause of morbidity and mortality among cancer survivors. Although cardiac rehabilitation is recommended for cardiovascular disease prevention and management, high-quality randomized controlled evidence regardin…
Sponsor: Xinjiang Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Magnetic pulses to the brain may curb etomidate cravings
Disease control Not yet recruitingThe goal of this clinical trial is to learn if high-frequency rTMS works to treat etomidate addiction in adults. It will also learn about the safety and tolerability of rTMS. The main questions it aims to answer are: * Does active rTMS reduce craving, amount of etomidate use, fr…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Choice over prescription: could picking your own workouts beat a Physio's plan for back pain?
Symptom relief Not yet recruitingChronic low back pain is a public health issue affecting over 20% of the Spanish population, causing disability, reduced quality of life, and work absenteeism. Over the past decades, the benefits of physical exercise for improving symptoms in patients with chronic low back pain h…
Sponsor: University of Cadiz • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a new Opioid-Like drug prevent dangerous blood pressure spikes during anesthesia?
Disease control Not yet recruitingGeneral anesthesia tracheal intubation causes sympathetic activation and hemodynamic stress response, which increases perioperative cardiovascular risk, especially in elderly subjects. Tegileridine fumarate is a novel μ-opioid receptor G protein-biased agonist. However, the optim…
Sponsor: Shiyou Wei • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a Dual-Pronged play therapy boost autistic Toddlers' social and emotional growth?
Disease control Not yet recruitingAutistic toddlers often need support to develop both social-communication and social-emotional skills. Social communication (such as making requests or sharing attention) is usually addressed in early intervention, but social-emotional needs (such as expressing feelings or learni…
Sponsor: Baylor University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could starting dialysis sooner save more hearts?
Disease control Not yet recruitingCAPITAL OFFLOAD-SHOCK will aim to answer if early use of renal replacement therapy, like dialysis, in patients with reduced body fluids causing the heart to be unable to pump enough blood through the body reduces in-hospital death when compared to the current standard of care. Th…
Phase 4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a Two-Drug combo keep aggressive lymphoma at bay?
Disease control Not yet recruitingThis is a prospective, single-arm, single-center clinical study evaluating pomalidomide combined with rituximab as maintenance treatment in young high-risk patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who have achieved at least a partial response after firs…
Phase 4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a 7-Day antibiotic course replace 3 weeks for silent STI?
Disease control Not yet recruitingLymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by the L genotypes of C. trachomatis. Proctitis is the main clinical manifestation of infection in the current LGV epidemic. However, recent European studies reported that about 25% of the anal LGV in…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can your own blood ease nerve pain after disc surgery?
Symptom relief Not yet recruitingThe aim of this study is to assess neuropathic pain in the lower limb at 6 months post-operation in patients who have undergone surgery for a lumbar disc herniation using single-port endoscopic discectomy combined with an epidural PRP injection. This study is based on the hypoth…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Which prostate cancer drug delays the next treatment longer? a Real-World showdown
Knowledge-focused Not yet recruitingThe purpose of this real-world study of electronic medical records is to look back to compare the time to next treatment after initial treatment with enzalutamide or darolutamide in addition to androgen deprivation therapy (ADT). ADT is a hormone therapy used to stop testosterone…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a pill tame obesity? new oral drug heads to early human tests
Disease control Not yet recruitingThis is a Phase 1 study of IBI3042, an investigational oral medicine being developed as a potential treatment for overweight and obesity. The study has two parts. Part A will evaluate single doses of IBI3042 in healthy adults. Part B will evaluate repeated doses for 13 weeks in a…
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can kids with blood infections skip the IV earlier?
Disease control Not yet recruitingThis nationwide, multicenter, randomized, non-inferiority trial of children and adolescents with uncomplicated bloodstream infections aims to investigate if early-oral antibiotic switch (experimental arm) is non-inferior to standard intravenous antibiotics (control arm) with resp…
Phase 4 • Sponsor: Ulrikka Nygaard • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a 20-Minute brain zap ease depression in pregnancy?
Symptom relief Not yet recruitingThe purpose of this pilot trial is to primarily assess safety, feasibility, and tolerability of PandA-tACS in antenatal depression and determine whether a single PandA-tACS session produces greater left dlPFC aperiodic slope flattening (reduction) from pre- to post-stimulation th…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can a single infusion prevent organ failure in severe pancreatitis?
Disease control Not yet recruitingThis is an early phase clinical study. Patients who are at high risk of developing severe acute pancreatitis will be screened. Participants will be randomly assigned to receive either SGC001 injection or a placebo injection that contains no active medicine. The study will check h…
Phase 2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC